G protein-coupled receptor 143
Zuletzt aktualisiert 18. Aug 2020
Erfüllt die redaktionelle Richtlinien
- HerunterladenHerunterladen
- Teilen
- Language
- Diskussion
- Ask Patient
- Audio-Version
- Zu bevorzugten Quellen bei Google hinzufügen
Der GPR143 gene, also known as OA1, provides instructions for making a protein that is involved in the coloring (pigmentation) of the eyes and skin. This protein is made in the light-sensitive tissue at the back of the eye (the retina) and in skin cells. The GPR143 protein is part of a signaling pathway that controls the growth and maturation of melanosomes, which are cellular structures that produce and store a pigment called melanin. Melanin is the substance that gives skin, hair, and eyes their colour. In the retina, this pigment also plays a critical role in normal vision.
Normal function
Der GPR143 gene, also known as OA1, provides instructions for making a protein that is involved in the coloring (pigmentation) of the eyes and skin. This protein is made in the light-sensitive tissue at the back of the eye (the retina) and in skin cells. The GPR143 protein is part of a signaling pathway that controls the growth and maturation of melanosomes, which are cellular structures that produce and store a pigment called melanin. Melanin is the substance that gives skin, hair, and eyes their colour. In the retina, this pigment also plays a critical role in normal vision.
Conditions referring to this gene or chromosome
Other names
GP143_HUMAN
OA1
ocular albinism 1 (Nettleship-Falls)
ocular albinism type 1 protein
Related patient information and medicines

Patient information leaflet
Brustkrebs
...:/health/breast-cancer-leaflet](https://patient.info/health/breast-cancer-leaflet) Follow Patient: Website: [/](https://patient.info/) Facebook: [https://www.facebook.com/patient](https://www.facebook.com/patient) Twitter: [https://twitter.com/patient](https://twitter.com/patient) Pinterest:.

Patient information leaflet
Kehlkopfkrebs
(The throat is usually sprayed ... Dr Krishna Vakharia, 16th October 2023 The National Institute for Health and Care Excellence (NICE) has recommended that a person should receive a diagnosis or ruling out of cancer within 28 days of being referred urgently by their GP for suspected cancer. The same instrument has a light source similar to a nasal.

Patient information leaflet
Diabetische Nierenerkrankung
Diabetische Nierenerkrankung (diabetic nephropathy) is a complication that occurs in some people with diabetes. Diabetic kidney disease is one of the causes of chronic kidney disease Chronic kidney disease , a long-term condition where the kidneys do not work as well as they should. In diabetic kidney disease, the filters of the kidneys, the glomeruli,.

Patient information leaflet
Nephrotisches Syndrom
Nephrotic syndrome is a condition where the 'filters' in the kidney become 'leaky' and large amounts of protein leak from the blood into the urine. The main symptom is fluid retention (oedema) which is mainly due to the low protein level in the blood. Various diseases can cause nephrotic syndrome, some more serious than others. A syndrome is a set.

Patient information leaflet
Kann ich Chaga und Cordyceps zusammen einnehmen?
Nehmen chaga and cordyceps together may increase the risk of bruising or bleeding. Caffeine Cordyceps may have mild stimulant properties and can interagieren mit adenosine receptors. ...inesOur Wechselwirkungs-Checker für Medikamente helps you check whether your prescriptions, over-the-counter medicines, und Nahrungsergänzungsmittel are safe to take zusammen. Disclaimer.

Patient information leaflet
Kann ich Apixaban und Rybelsus zusammen einnehmen?
These two medicines work in different ways and do not... Why this happens Apixaban is an anticoagulant (blood thinner) that works by blocking a clotting factor called Factor Xa. Rybelsus ist a GLP-1 receptor agonist used for type 2 diabetes that mimics a natural hormone to lower Blut sugar. They are processed by different pathways in the liver and.
Weiterführende Lektüre und Referenzen
- G protein-coupled receptor 143; MedlinePlus, National Library of Medicine.
- Camand O, Boutboul S, Arbogast L, Roche O, Sternberg C, Sutherland J, Levin A, Heon E, Menasche M, Dufier J, Abitbol M. Mutational analysis of the OA1 gene in ocular albinism. Ophthalmic Genet. 2003 Sep;24(3):167-73. doi: 10.1076/opge.24.3.167.15605.
- Cortese K, Giordano F, Surace EM, Venturi C, Ballabio A, Tacchetti C, Marigo V. The ocular albinism type 1 (OA1) gene controls melanosome maturation and size. Invest Ophthalmol Vis Sci. 2005 Dec;46(12):4358-64. doi: 10.1167/iovs.05-0834.
- Innamorati G, Piccirillo R, Bagnato P, Palmisano I, Schiaffino MV. The melanosomal/lysosomal protein OA1 has properties of a G protein-coupled receptor. Pigment Cell Res. 2006 Apr;19(2):125-35. doi: 10.1111/j.1600-0749.2006.00292.x.
- Lewis RA. Ocular Albinism, X-Linked - RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY. 2004 Mar 12 [updated 2015 Nov 19]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK1343/
- Mayeur H, Roche O, Vetu C, Jaliffa C, Marchant D, Dollfus H, Bonneau D, Munier FL, Schorderet DF, Levin AV, Heon E, Sutherland J, Lacombe D, Said E, Mezer E, Kaplan J, Dufier JL, Marsac C, Menasche M, Abitbol M. Eight previously unidentified mutations found in the OA1 ocular albinism gene. BMC Med Genet. 2006 Apr 28;7:41. doi: 10.1186/1471-2350-7-41.
- Oetting WS. New insights into ocular albinism type 1 (OA1): Mutations and polymorphisms of the OA1 gene. Hum Mutat. 2002 Feb;19(2):85-92. doi: 10.1002/humu.10034.
- Schiaffino MV, Tacchetti C. The ocular albinism type 1 (OA1) protein and the evidence for an intracellular signal transduction system involved in melanosome biogenesis. Pigment Cell Res. 2005 Aug;18(4):227-33. doi: 10.1111/j.1600-0749.2005.00240.x.
- Shen B, Samaraweera P, Rosenberg B, Orlow SJ. Ocular albinism type 1: more than meets the eye. Pigment Cell Res. 2001 Aug;14(4):243-8. doi: 10.1034/j.1600-0749.2001.140403.x.
Artikelverlauf
Artikel auch verfügbar in Englisch, Deutsch, Spanisch, Französisch, Italienisch, Portugiesisch, Hindi, Hebräisch, Arabisch, und Schwedisch.
18. Aug 2020 | Neueste Version
1 Jul 2007 | Ursprünglich veröffentlicht
Teilen Sie Ihre Gedanken oder Erfahrungen mit anderen in unserem Patientengemeinschaften.
Abonnieren Sie den Patienten-Newsletter
Ihre wöchentliche Dosis klarer, vertrauenswürdiger Gesundheitsberatung - geschrieben, um Ihnen zu helfen, sich informiert, selbstbewusst und in Kontrolle zu fühlen.
Durch das Abonnieren akzeptieren Sie unsere Datenschutzrichtlinie. Sie können sich jederzeit abmelden. Wir verkaufen Ihre Daten niemals.

